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1. Data {#sec1}
=======

Datasets presented here were employed in the main work "DMSO impairs the transcriptional program for maternal-to-embryonic transition by altering histone acetylation" Kang et al., 2020 \[[@bib1]\]. [Fig. 1](#fig1){ref-type="fig"} illustrates the experimental procedure. RNA-seq analysis was performed in 2-cell mouse embryos cultured after supplementation of 2% DMSO. The raw data generated from Illumina sequencing were deposited on the Gene Expression Omnibus (GEO) with the reference number GSE124598 (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE124598>).Fig. 1**Pipeline of RNA-Seq analysis for DMSO-treated 2-cells.** Based on gene-level expression estimation, 19,556 genes were expressed in common in both control and treated groups.Fig. 1

RNA-seq analysis was performed in the 2-cell embryos with/without DMSO supplementation. In total, 3,742, which is ∼20.29% of the total valid genes, genes were differentially expressed in DMSO-treated embryo compared with control embryo with criteria of FDR \< 0.05. Of these differentially expressed genes, 1,415 genes were up-regulated, whereas 1,758 genes were down-regulated in DMSO-treated embryo ([Fig. 2](#fig2){ref-type="fig"}). DEGs were significantly enriched in total 72 KEGG and REACTOME pathways terms (adjusted p-value \< 0.01) and the terms were mainly clustered into 4 characterized groups ([Fig. 3](#fig3){ref-type="fig"}).Fig. 2**Up- and Down-regulated differentially expressed genes (DEGs) by DMSO in 2-cell embryos.** (A) Each DEG is plotted with logged p-value and fold change values as scatter plot. Up- and down-regulated genes are represented as red and green dots, respectively (\|fold change\| \>2; *p*-value \< 0.05). (B) Significantly changed DEGs (n = 3,173) were hierarchically clustered with heatmap based on logged TPM value. Detailed DEGs and TPM values are listed in supplementary data and data repository (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE124598>).Fig. 2Fig. 3**Interactive string network of KEGG and REACTOME pathways for DEGs.** Enriched KEGG and REACTOME pathways for DEGs are mainly clustered as Group 1--4 using ClueGO plug-in in Cytoscape 3.6. Detailed genes on each pathway node are listed in [Table 1](#tbl1){ref-type="table"} and [Supplementary Data](#appsec1){ref-type="sec"}.Fig. 3

Next, we interpreted potential interactive pathways among DEGs associated with epigenetic gene expression, histone modifications (acetylation and methylation) in DMSO treated group using cerebral layout ([Fig. 4](#fig4){ref-type="fig"}). Most of DEGs for histone modifications and binding events are significantly depressed at specific and highly characteristic genomic elements and locations in DMSO-treated groups, indicating that DMSO exhibits specific regulatory mechanisms related to regulation of transcription factors, compared with control embryos.Fig. 4**Interrelation network among enriched DEGs for epigenetic gene expression and histone modification.** Based on GO enrichment test by ClueGO, heat maps and pathway-like visualizations for DEGs that associated with epigenetic gene expression (A), histone methylation (B) and histone acetylation (C) were created using CluePedia plug-in in Cytoscape 3.6 software. Functional relations between DEGs were drawn by colored lines, which represent activation (green), catalysis (purple), inhibition (red), protein modification (light purple) and reaction (black).Fig. 4

In this study, we proved our hypothesis by RNA-seq analysis to monitor the early embryonic impacts after exposure to DMSO and identified previously unknown underlying molecular mechanisms that explain the DMSO-induced embryonic toxicity, embryo loss, and infertility. Our study suggests for the first time that DMSO exposure induces a significant alteration in gene expression and the functionality of preimplantation embryos via alternations in epigenetic reprogramming. Thus, our findings emphasize that the use of DMSO as a standard control test or solvent requires far more cautious consideration, because DMSO can alter cell function by acting as a proteasome or HDAC inhibitor as well as inducing cell toxicity.Table 1KEGG and REACTOME pathway analysis in DMSO-treated 2-cell embryos.Table 1Pathway IDPathway Termadj_pvalueNo. of Genes% Genes1R-MMU:2262752Cellular responses to stress0.001072339224.022R-MMU:72702Ribosomal scanning and start codon recognition0.001096722341.073R-MMU:1234176Oxygen-dependent proline hydroxylation of Hyposia-inducible factor alpha0.001153782440.004R-MMU:72689Formation of a pool of free 40S subunits0.001179912044.445R-MMU:8948751Regulation of PTEN stability and activity0.001183172539.066R-MMU:373076Class A/1 (Rhodopsin-like receptors)0.00134226206.257R-MMU:4641258Degradation of DVL0.001476752241.518R-MMU:74158RNA Polymerase III Transcription0.001541921748.579R-MMU:76046RNA Polymerase III Transcription Initiation0.001541921748.5710R-MMU:6807505RNA polymerase II transcribes snRNA genes0.001604512736.9911R-MMU:69275G2/M Transition0.001707955028.5712R-MMU:212436Generic Transcription Pathway0.0020978613521.6313R-MMU:453274Mitotic G2-G2/M phases0.002140725028.2514R-MMU:4608870Asymmetric localization of PCP proteins0.002220222339.6615R-MMU:5689603UCH proteinases0.002789953233.3316R-MMU:174113SCF-beta-TrCP mediated degradation of Emi10.002886642141.1817R-MMU:8854050FBXL7 down-regulates AURKA during mitotic entry and in early mitosis0.002886642141.1818R-MMU:5687128MAPK6/MAPK4 signaling0.003008732636.6219R-MMU:174154APC/C:Cdc20 mediated degradation of Securin0.003128542438.1020R-MMU:5621481C-type lectin receptors (CLRs)0.0034213531.8221R-MMU:73863RNA Polymerase I Transcription Termination0.003802341550.0022R-MMU:1236978Cross-presentation of soluble exogenous antigens (endosomes)0.003886762041.6723R-MMU:174178APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G10.004177392536.7624R-MMU:174184Cdc20:Phospho-APC/C mediated degradation of Cyclin A0.004177392536.7625R-MMU:351202Metabolism of polyamines0.00421542934.5226R-MMU:68882Mitotic Anaphase0.005313075227.0827KEGG:03008Ribosome biogenesis in eukaryotes0.005452873631.0328R-MMU:179419APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfaction of the cell cycle checkpoint0.005602892536.2329R-MMU:1234174Regulation of Hypoxia-inducible Factor (HIF) by oxygen0.005798292436.9230R-MMU:2262749Cellular response to hypoxia0.005798292436.9231R-MMU:5610780Degradation of GLI1 by the proteasome0.005840492139.6232R-MMU:72086mRNA Capping0.007707141450.0033R-MMU:112382Formation of RNA Pol II elongation complex0.008207432138.8934R-MMU:75955RNA Polymerase II Transcription Elongation0.008207432138.8935R-MMU:2555396Mitotic Metaphase and Anaphase0.008340285226.9436R-MMU:6807070PTEN Regulation0.008890333431.4837R-MMU:3858494Beta-catenin independent WNT signaling0.010052713730.0838R-MMU:2871837FCERI mediated NF-kB activation0.011196742635.1439R-MMU:5358346Hedgehog ligand biogenesis0.011212372237.2940R-MMU:5607761Dectin-1 mediated noncanonical NF-kB signaling0.011330352138.1841R-MMU:5610785GLI3 is processed to GLI3R by the proteasome0.011330352138.1842R-MMU:5676590NIK\--\>noncanonical NF-kB signaling0.011330352138.1843R-MMU:68827CDT1 association with the CDC6:ORC:origin complex0.011330352138.1844R-MMU:73772RNA Polymerase I Promoter Escape0.012711691448.2845KEGG:03013RNA transport0.013961224627.5446R-MMU:2454202Fc epsilon receptor (FCERI) signaling0.014246133630.0047R-MMU:5658442Regulation of RAS by GAPs0.014482492335.9448R-MMU:68867Assembly of the pre-replicative complex0.014482492335.9449R-MMU:73762RNA Polymerase I Transcription Initiation0.014799771840.9150R-MMU:5205647Mitophagy0.015549931350.0051R-MMU:77075RNA Pol II CTD phosphorylation and interaction with CE0.015549931350.0052R-MMU:176409APC/C:Cdc20 mediated degradation of mitotic proteins0.016452482535.2153R-MMU:176814Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins0.018506552534.7254R-MMU:113418Formation of the Early Elongation Complex0.02033271446.6755R-MMU:9006925Intracellular signaling by second messengers0.020517256224.6056R-MMU:2467813Separation of Sister Chromatids0.020550074826.5257R-MMU:176408Regulation of APC/C activators between G1/S and early anaphase0.021935022633.3358KEGG:05206MicroRNAs in cancer0.02406351196.7659R-MMU:76061RNA Polymerase III Transcription Initiation From Type 1 Promoter0.025598611348.1560R-MMU:76066RNA Polymerase III Transcription Initiation From Type 2 Promoter0.025598611348.1561R-MMU:202424Downstream TCR signaling0.025705742832.5662R-MMU:72731Recycling of eIF2:GDP0.02607639777.7863R-MMU:71291Metabolism of amino acids and derivatives0.03045376024.6964R-MMU:76071RNA Polymerase III Transcription Initiation From Type 3 Promoter0.041056321346.4365R-MMU:202403TCR signaling0.041073353130.1066R-MMU:174143APC/C-mediated degradation of cell cycle proteins0.041462552732.1467R-MMU:453276Regulation of mitotic cell cycle0.041462552732.1468R-MMU:69304Regulation of DNA replication0.044400042433.3369R-MMU:68949Orc1 removal from chromatin0.045075832334.3370R-MMU:69052Switching of origins to a post-replicative state0.045075832334.3371R-MMU:1236975Antigen processing-Cross presentation0.046959472731.7672R-MMU:4086400PCP/CE pathway0.046959472731.76

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Animals and embryo collection {#sec2.1}
----------------------------------

BDF1 (C57BL/6 × DBA/2; F1; Orient Bio Co. Ltd) mice (8--12 weeks olds) were used for analysis according to guidelines approved by the committee on animal care and use at Konkuk University (IACUC approval number: KU18199). Intraperitoneally injection was carried out in female mice were with pregnant mare\'s serum gonadotropin (PMSG; G4527, Sigma Aldrich; 5IU) followed human chorionic gonadotropin (hCG; CG10, Sigma Aldrich; 5IU) 48 h later, then mated with male mice. Fertilized oocytes with two pronuclei were collected from oviduct at 18--20 h of post hCG injection and each 10 zygotes was cultured in 20ul KSOM (95mM NaCl, 2.5mM KCl, 0.35mM KH~2~PO~4~, 0.2mM MgSO~4~, 10mM Sodium Lactate, 0.2mM Glucose, 0.2mM Sodium pyruvate, 25mM NaHCO~3~, 1mM Glutamine, 0.01mM Ethylenediaminetetraacetic acid, 5mg/ml Bovine albumine serum) supplemented with 2% DMSO (D2650, Sigma Aldrich) or without. BDF1 embryos with second polar body were collected and cultured in KSOM with/without 2% DMSO for further analysis.

2.2. Library preparation and RNA-seq {#sec2.2}
------------------------------------

Fifty 2-cell embryos from each control and DMSO-treated group were directly subjected to cDNA synthesis using SMARTer® Ultra® Low Input RNA Kit (634940, Clonetech) according to the manufacturer\'s instructions. RNA quality was determined using the Agilent Bioanalyzer High Sensitivity DNA kit (5067-4626, Agilent). The synthesized cDNAs with 150-200bp size were used for the preparation of sequencing library using Low Input DNA Library Prep Kit (634946, Clonetech) according to the manufacturer\'s instructions, and subjected to size selection, followed paired-end reads data were obtained by performing 50 bp sequencing using HiSeq2500 (Illumina).

2.3. RNA-seq data analysis {#sec2.3}
--------------------------

Reads were pseudomapped using kallisto \[[@bib2]\] with default parameters by transcriptome index from FASTA formatted transcriptomes files (GRCm38.re179) of ENSEMBL transcript database (mm10). Transcript abundance of each gene was quantified with the parameters (quant -t -b 100) as transcripts per kilobase million (TPM) using kallisto. Gene-scaled TPM values for each gene transcript were summed by tximport \[[@bib3]\] in R/Bioconductor. Differentially expressed gene (DEG) were analyzed by DESeq2 \[[@bib4]\] in R/Bioconductor with the parameters (baseMean counts \>14; false discovery rate (FDR) \< 0.05).

2.4. Pathway enrichment test and *in silico* analysis {#sec2.4}
-----------------------------------------------------

DEGs were tested for pathway enrichment score in KEGG and REACTOME pathways using ClueGO \[[@bib5]\] plug-in in Cytoscape 3.6 (<http://www.cytoscape.org>). To search potential associations among DEGs specific gene ontology (GO) terms regarding epigenetic gene expression, histone acetylation and histone methylation, ClueGO enrichment test were integrated into CluePedia \[[@bib6]\] plug-in in Cytoscape 3.6 and analyzed.
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